(Q48206561)

9 February 2018

title

The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801. (English)

1 reference

9 February 2018

author name string

R N Auer

series ordinal

1

1 reference

9 February 2018

K C Coulter

series ordinal

2

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

published in

Acta Neuropathologica

1 reference

9 February 2018

volume

87

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

1-7

1 reference

9 February 2018

The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique

cites work

1 reference

12 December 2020

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

1 reference

12 December 2020

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

1 reference

12 December 2020

MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain

1 reference

12 December 2020

Cerebral blood flow and ischemia-induced neurotransmitter release in the striatum of aged spontaneously hypertensive rats

1 reference

12 December 2020

Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex

1 reference

12 December 2020

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

1 reference

12 December 2020

Status epilepticus in well-oxygenated rats causes neuronal necrosis

1 reference

12 December 2020

Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat.

1 reference

12 December 2020

SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons

1 reference

12 December 2020

Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats

1 reference

12 December 2020

Autoradiographic assessment of the effects of N-methyl-d-aspartate (NMDA) receptor antagonists in vivo

1 reference

12 December 2020

Phencyclidine, dizocilpine, and cerebrocortical neurons

1 reference

12 December 2020

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke

1 reference

12 December 2020

Early axonal lesion and preserved microvasculature in epilepsy-induced hypermetabolic necrosis of the substantia nigra

1 reference

12 December 2020

Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat.

1 reference

12 December 2020

Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

1 reference

12 December 2020

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia

1 reference

12 December 2020

Metabolic alterations underlying the development of hypermetabolic necrosis in the substantia nigra in status epilepticus

1 reference

12 December 2020

N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism

1 reference

12 December 2020

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

1 reference

12 December 2020

Identifiers

DOI

10.1007/S004010050050

1 reference

9 February 2018

1 reference

9 February 2018